Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinoma.

Taddei PJ, Howell RM, Krishnan S, Scarboro SB, Mirkovic D, Newhauser WD.

Phys Med Biol. 2010 Dec 7;55(23):7055-65. doi: 10.1088/0031-9155/55/23/S07. Epub 2010 Nov 12.

2.

Dose perturbations and image artifacts caused by carbon-coated ceramic and stainless steel fiducials used in proton therapy for prostate cancer.

Cheung J, Kudchadker RJ, Zhu XR, Lee AK, Newhauser WD.

Phys Med Biol. 2010 Dec 7;55(23):7135-47. doi: 10.1088/0031-9155/55/23/S13. Epub 2010 Nov 12.

PMID:
21076190
3.

Fractionation effects in particle radiotherapy: implications for hypo-fractionation regimes.

Carabe-Fernandez A, Dale RG, Hopewell JW, Jones B, Paganetti H.

Phys Med Biol. 2010 Oct 7;55(19):5685-700. doi: 10.1088/0031-9155/55/19/005. Epub 2010 Sep 8.

PMID:
20826903
4.

Comparison of liver tumor motion with and without abdominal compression using cine-magnetic resonance imaging.

Eccles CL, Patel R, Simeonov AK, Lockwood G, Haider M, Dawson LA.

Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):602-8. doi: 10.1016/j.ijrobp.2010.04.028. Epub 2010 Aug 1.

PMID:
20675063
5.

Potentials and limitations of guiding liver stereotactic body radiation therapy set-up on liver-implanted fiducial markers.

Wunderink W, Méndez Romero A, Seppenwoolde Y, de Boer H, Levendag P, Heijmen B.

Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1573-83. doi: 10.1016/j.ijrobp.2009.10.040. Epub 2010 Apr 14.

PMID:
20399034
6.

Radiological use of fast protons.

WILSON RR.

Radiology. 1946 Nov;47(5):487-91. No abstract available.

PMID:
20274616
7.

Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis.

Sugahara S, Nakayama H, Fukuda K, Mizumoto M, Tokita M, Abei M, Shoda J, Matsuzaki Y, Thono E, Tsuboi K, Tokuuye K.

Strahlenther Onkol. 2009 Dec;185(12):782-8. doi: 10.1007/s00066-009-2020-x.

PMID:
20013087
8.

Biological characteristics of carbon-ion therapy.

Ando K, Kase Y.

Int J Radiat Biol. 2009 Sep;85(9):715-28. doi: 10.1080/09553000903072470. Review.

PMID:
19728191
9.

Proton beam therapy for hepatocellular carcinoma: the University of Tsukuba experience.

Nakayama H, Sugahara S, Tokita M, Fukuda K, Mizumoto M, Abei M, Shoda J, Sakurai H, Tsuboi K, Tokuuye K.

Cancer. 2009 Dec 1;115(23):5499-506. doi: 10.1002/cncr.24619.

10.

Inter- and intrafraction variability in liver position in non-breath-hold stereotactic body radiotherapy.

Case RB, Sonke JJ, Moseley DJ, Kim J, Brock KK, Dawson LA.

Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):302-8. doi: 10.1016/j.ijrobp.2009.03.058. Epub 2009 Jul 21.

PMID:
19628342
11.

Imaging with subwavelength resolution by a generalized superlens at infrared wavelengths.

Casse BD, Lu WT, Banyal RK, Huang YJ, Selvarasah S, Dokmeci MR, Perry CH, Sridhar S.

Opt Lett. 2009 Jul 1;34(13):1994-6.

PMID:
19571977
12.

Respiratory gating with EPID-based verification: the MDACC experience.

Briere TM, Beddar S, Balter P, Murthy R, Gupta S, Nelson C, Starkschall G, Gillin MT, Krishnan S.

Phys Med Biol. 2009 Jun 7;54(11):3379-91. doi: 10.1088/0031-9155/54/11/007. Epub 2009 May 13.

PMID:
19436104
13.

Proton beam therapy for large hepatocellular carcinoma.

Sugahara S, Oshiro Y, Nakayama H, Fukuda K, Mizumoto M, Abei M, Shoda J, Matsuzaki Y, Thono E, Tokita M, Tsuboi K, Tokuuye K.

Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):460-6. doi: 10.1016/j.ijrobp.2009.02.030. Epub 2009 May 7.

PMID:
19427743
14.

A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma.

Fukumitsu N, Sugahara S, Nakayama H, Fukuda K, Mizumoto M, Abei M, Shoda J, Thono E, Tsuboi K, Tokuuye K.

Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):831-6. doi: 10.1016/j.ijrobp.2008.10.073. Epub 2009 Mar 21.

PMID:
19304408
15.

Safety and efficacy of percutaneous fiducial marker implantation for image-guided radiation therapy.

Kothary N, Heit JJ, Louie JD, Kuo WT, Loo BW Jr, Koong A, Chang DT, Hovsepian D, Sze DY, Hofmann LV.

J Vasc Interv Radiol. 2009 Feb;20(2):235-9. doi: 10.1016/j.jvir.2008.09.026. Epub 2008 Nov 18.

PMID:
19019700
16.

Proton radiotherapy for liver tumors: dosimetric advantages over photon plans.

Wang X, Krishnan S, Zhang X, Dong L, Briere T, Crane CH, Martel M, Gillin M, Mohan R, Beddar S.

Med Dosim. 2008 Winter;33(4):259-67. doi: 10.1016/j.meddos.2007.04.008.

PMID:
18973852
17.

Why more needs to be known about RBE effects in modern radiotherapy.

Dale RG, Jones B, Cárabe-Fernández A.

Appl Radiat Isot. 2009 Mar;67(3):387-92. doi: 10.1016/j.apradiso.2008.06.013. Epub 2008 Jun 22. Review.

PMID:
18701310
18.

Image-guided radiotherapy for liver cancer using respiratory-correlated computed tomography and cone-beam computed tomography.

Guckenberger M, Sweeney RA, Wilbert J, Krieger T, Richter A, Baier K, Mueller G, Sauer O, Flentje M.

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):297-304. doi: 10.1016/j.ijrobp.2008.01.005.

PMID:
18406894
19.

Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis.

Mizumoto M, Tokuuye K, Sugahara S, Nakayama H, Fukumitsu N, Ohara K, Abei M, Shoda J, Tohno E, Minami M.

Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):462-7. doi: 10.1016/j.ijrobp.2007.09.056. Epub 2008 Feb 19.

PMID:
18243571
20.

4D-CT imaging with synchronized intravenous contrast injection to improve delineation of liver tumors for treatment planning.

Beddar AS, Briere TM, Balter P, Pan T, Tolani N, Ng C, Szklaruk J, Krishnan S.

Radiother Oncol. 2008 Jun;87(3):445-8. doi: 10.1016/j.radonc.2007.12.009. Epub 2008 Jan 14.

PMID:
18194819

Supplemental Content

Support Center